PARIS, FRANCE, 24 April 2023 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical company, announced today the appointment of Sandra Silvestri, M.D., …

Sandra Silvestri, M.D., Ph.D., joined Ipsen in 2023 as Executive Vice President, Chief Medical Officer and Head of Global Medical Affairs, Patient Safety and Patient Affairs.

Sandra Silvestri, M.D., Ph.D., joined Ipsen in 2023 as Executive Vice President, Chief Medical Officer and heading Global Medical Affairs, Patient Safety and Patient Affairs.

View the profiles of people named Sandra Silvestri. Join Facebook to connect with Sandra Silvestri and others you may know. Facebook gives people the...

PARIS, FRANCE, 24 April 2023 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical company, announced today the appointment of Sandra Silvestri, M.D., …

Apr 24, 2023 · Ipsen, a global specialty-driven biopharmaceutical company, announced the appointment of Sandra Silvestri, M.D., Ph.D., as EVP, Chief Medical Officer and Head of …

Sandra Silvestri, MD, PhD, currently serves as Executive Vice President and Chief Medical Officer at Ipsen, and as a member of the Board of Directors at GENFIT.

We’re thrilled to welcome Sandra Silvestri, MD, PhD to Ipsen as EVP, Chief Medical Officer and Head of Global Medical Affairs, Patient Safety and Patient Affairs. Sandra’s deep experience in ...

Dec 10, 2023 · View Sandra Silvestri, MD, PhD’s profile on LinkedIn, a professional community of 1 billion members. Executive Vice President and Board Member with 20 years of …

Sandra Silvestri is the EVP, Chief Medical Officer, Head of Global Medical Affairs, Patient Safety and Patient Affairs of Ipsen. She previously worked at San Donato Hospital as an Endocrine …